Head-to-head · Cost-Efficiency Index
Levers Health vs Midi Health
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Levers Health
Shoppers interested in a separate low-dose/microdosing GLP-1 tier alongside standard semaglutide or tirzepatide programs.
Visit Levers HealthMidi Health
Cost-first shoppers who want women already managing menopause who want their GLP-1 prescriber on the same platform, with no separate membership fee.
Visit Midi HealthThe verdict
Levers Health and Midi Health tie on the Cost-Efficiency Index at 57/100, so neither wins outright on the numbers. For most shoppers we'd start with Levers Health (ranked #307, a hair above #308) — Shoppers interested in a separate low-dose/microdosing GLP-1 tier alongside standard semaglutide or tirzepatide programs. But Midi Health is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Levers Health.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Levers Health | Midi Health |
|---|---|---|
| Cost-Efficiency Index | 57/100 | 57/100 |
| Semaglutide / mo | $247/mo (1.25 mg dose, compounded) | $166/mo (0.5 mg dose, plus a separate fee, compounded) |
| Tirzepatide / mo | $296/mo (all doses, compounded) | $210/mo (2.5 mg dose, plus a separate fee, compounded) |
| Semaglutide / yr (modeled) | $2,964 | $1,992 |
| Tirzepatide / yr (modeled) | $3,552 | $2,520 |
| Coverage | Coverage not published | All 50 states |
| Oral / sublingual | No | No |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #307 | #308 |
Levers Health
57/100Where the value is
- Free shipping stated on every plan ('Free shipping. always.')
- Both semaglutide and tirzepatide offered, plus a distinct low-dose/microdose GLP-1 product line advertised from $123/mo
- Named LLC legal entity (Levers Health LLC) rather than an anonymous storefront
The tradeoffs
- No pharmacy or prescribing physician is named anywhere — only generic 'a state-licensed pharmacy' and 'Licensed Medical Doctors' language
- The higher-dose 'Max Subscription' (semaglutide, up to 2.5mg/wk) and tirzepatide 'Low-Dose Plan' prices are not disclosed on their own product pages
Midi Health
57/100Where the value is
- No membership fee — the site states outright 'You only pay for your care and your medications'
- Medication price already includes shipping and supplies, so the listed number is closer to the true out-of-pocket cost than sites that add fees later
- Dose-tiered pricing is published transparently: compounded semaglutide $165.90-$355.00/mo, compounded tirzepatide $210.00-$434.00/mo depending on dose
The tradeoffs
- The advertised 'Weekly doses start at $34' teaser on the weight-management overview page refers to microdosing, not the standard program — the real 4-week program cost starts at $165.90/mo, over 4x the teaser figure
- Weight care is not Midi's core identity — it's layered onto a menopause/HRT platform, so patients whose only need is GLP-1 may find a weight-loss-only provider more streamlined
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.